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Aims: Babassu is the common Brazilian name of Orbignya speciosaMart. (Arecaceae). The fruits are used for sev-
eral disorders. In the present study, the antinociceptive effects of the ethanol extract (EE) and dichloromethane
fraction (DF) obtained from leaves were investigated, as well as apigenin using nociception models (acetic
acid-induced abdominal writhing, formalin, and hot plate).
Main methods: Mice were treated with EE, DF (10, 30, and 100 mg/kg, p.o.), apigenin (1 mg/kg, p.o.), morphine
(5 mg/kg, s.c.), acetylsalicylic acid (100 mg/kg, p.o.) or vehicle (0.1 ml, p.o.). The EE and DF reduced the contor-
tions induced by acetic acid. Both also reduced the licking response in the formalinmodel. In the hot platemodel,
the antinociceptive effects were, at least, equal to that shown by morphine. To elucidate the antinociceptive
mechanism of action of EE, DF, and apigenin the animalswere pre-treatedwith atropine (nonselectivemuscarinic
receptor antagonist, 1 mg/kg, s.c.), naloxone (opioid receptor antagonist, 1 mg/kg, s.c.), L-nitro arginine methyl
ester (L-NAME, nitric oxide synthase inhibitor, 3 mg/kg, s.c.) or mecamylamine (nicotinic receptor antagonist,
2 mg/kg, s.c.) and evaluated in the hot plate model.
Key ﬁndings: The antinociception produced by DF was abolished by atropine, naloxone or mecamylamine. The
effect of apigenin was signiﬁcantly blocked by atropine or naloxone.
Signiﬁcance: The results obtained indicated that EE and DF have antinociceptive activity that is mediated, at least
in part, by opioid and cholinergic systems. This effect can be attributed to the presence of apigenin, a ﬂavonoid in
the dichloromethane fraction.© 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Pain is one of the most prevalent conditions that limit the quality
of life. Although there is a great number of analgesic opioid and non
opioid drugs, there is some concern regarding the safety and side
effects of these drugs, such as ulcers, bleeding, and dependence,
which limit their clinical use (Jage, 2005).
The use of medicinal plants is a traditional method of providing
relief from illness and can be traced back over ﬁve millennia in sever-
al civilizations. Over the years, natural products have contributed
enormously to the development of important therapeutic drugs used
currently in modern medicine. The potential of higher plants as sources
for new drugs is still largely unexplored (Calixto et al., 2000).
Babassu is the popular name of Orbignya speciosa Mart. Barbosa
Rodrigues (Arecaceae, Palmae). This palm is native to the north,gia da Inﬂamação e do Óxido
Federal do Rio de Janeiro. Av.
0. 21944–970. Rio de Janeiro,
ndes).
vier OA license.northeast and central regions of Brazil. It forms extensive forests in
the states of Maranhão, Piauí, Tocantins, and Goiás. The babassu
palm has been used by Apinaye and Guajajara Indians from
north-eastern Brazil, yielding a variety of important products. The
palms provide food, fuel, shelter, ﬁbre, construction materials, and
medicine for these people (Balick, 1998).
Ethnopharmacological studies have indicated the use of mesocarp
from Babassu fruits for the treatment of chronic wounds, ulcerations,
dysmenorrhoea, menstrual pain, constipation, obesity, rheumatism,
leukaemia and inﬂammatory and venous diseases (Rego, 1995; Silva
and Parente, 2001; Renno et al., 2008). The kernels of the fruits are
also used for the treatment of urinary diseases. The ability of this
extract to reduce urinary tract symptoms (LUTS) among aging men,
usually caused by Benign Prostatic Hyperplasia (BPH), has been con-
ﬁrmed by our group (Reis de Souza et al., 2011).
The analgesic and anti-inﬂammatory properties of babassu meso-
carp were conﬁrmed experimentally using a chloroform extract of the
dried fruits (Maia, 1987). In addition, a polysaccharide isolated from
the mesocarp of fruits enhanced macrophage phagocytic activity
(Silva and Parente, 2001). The chronic oral treatment with an aque-
ous extract of babassu mesocarp in C5B1/6 mice showed signiﬁcant
anti-thrombotic effect (Azevedo et al., 2007) and induced an increase
Fig. 1. Structure of ﬂavonoid Apigenin.
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al., 2006). Traditionally, people use the fruits from Babassu to treat
disorders mentioned above and discard the leaves. The fruit may be
used when green in the smoking of rubber. When ripe, it is eaten as
a nutritious food. A liquid contained in the fruit stalk, or peduncle,
is fermented and drunk as an alcoholic beverage, much prized locally.
Fiber is taken from the exocarp, or outer layer of the fruit, and used
for various purposes. Stalks serve as timbers, and the leaves as cover-
ings and partitions in dwellings. Leaves are also used domestically for
making baskets and other plaited objects. Due to the great ethnobo-
tanical importance of this plant, ﬁnding out another use for its differ-
ent parts is an interesting approach. Therefore, in the present study,
we aimed to investigate the possible antinociceptive activity of frac-
tions obtained from O. speciosa Mart. leaves collected in a private
farm in the northeast of Brazil.Materials and methods
Plant material
O. speciosa leaves were collected at city of Teresina, Piauí state,
Brazil, in December, 2002. The plant was identiﬁed by Dr. Roseli
Faria Melo Barros. A voucher sample was deposited at the Herbarium
Graziela Barroso, Federal University of Piauí, and received the number
18,985.Preparation of fractions
The leaves of O. speciosa (1,000 g) were dried under airﬂow in an
oven between 400 and 50 °C and powdered in a mill of knives. The ex-
traction was performed by static maceration with ethanol. After
ﬁltration, the ethanol extract (EE) was concentrated under reduced
pressure yielding 29 g of brown syrup. EE was suspended in ethanol/
water (1:4) and partitioned successively in hexane, dichloromethane,
ethyl acetate and n-butanol, yielding 4.6, 4.9, 10.6, and 3.1 g, respec-
tively, after solvent evaporation. This procedure is in accordance
with previous publications from our group (Berrondo et al., 2003;
Amado et al., 2009).Fig. 2. HPLC of the pure apigenin (RT 11.51) after its pIsolation, puriﬁcation, and identiﬁcation of apigenin
Part of the dichloromethane fraction (1.5 g) was fractioned using
column chromatography in silica gel (Vetec 70–230 mesh) and gradi-
ent mixtures of dichloromethane and methanol up to pure methanol.
A total of 70 fractions were collected. Fractions 25 to 31, eluted with
dichloromethane/methanol 1:1.5, have shown a yellow spot after
thin layer chromatography. The combination of these fractions was
re-chromatographed to yield 3 mg of the ﬂavonoid apigenin, com-
prising 0.2% of the dichloromethane fraction. Also, one mg of apigenin
standard has been mixed with one mg of the isolate and a TLC has
been performed using different mobile phases, showing unequivocal-
ly that the isolate was in fact apigenin. The structure of apigenin
(Fig. 1) was established by NMR analysis, using mono- and
bi-dimensional experiments. It was also conﬁrmed by comparison
with literature data (Van Loo et al., 1986). Apigenin was also analysed
by HPLC and found to be greater than 98% pure (Fig. 2). The analysis
was performed on Waters HPLC system (Waters 600 controller with
PDA detector and 717 plus autosampler) using a C18 column
Nucleosil 120–5 C18 (4.6×250 mm). The optimum separation of
HPLC was carried out with a mobile phase composed of methanol and
0.2% phosphoric acid aqueous solution (58:42, v/v) at a ﬂow-rate of
1.0 ml/min. The volume of sample injected was 50 ml, the detective
wavelength and the column temperature were set at 350 nm and
30 °C, respectively.
Other constituents in the extract could be suggested based on
their TLC results. They are complexes mixtures of terpenes, steroids
and possibly other ﬂavonoids. It is important to mention that this ex-
tract is a complex mixture of small quantities of compounds from
where apigenin has been isolated and identiﬁed (Fig. 3).
Animals
All experiments were performed with male Swiss mice (18–25 g)
obtained from our own animal facilities. Animals were maintained in
a room with controlled temperature 22±2o C for 12 hr light/dark
cycle with free access to food and water. Twelve hours before each
experiment animals received only water, in order to avoid food inter-
ference with substances absorption. Animal care and research proto-
cols were in accordance with the principles and guidelines adopted
by Brazilian College of Animal Experimentation (COBEA), approved
by the Biomedical Science Institute/UFRJ, Ethical Committee for
Animal Research, and received the number DFBCICB-015.
Drugs and O. speciosa fractions administration
Acetylsalicylic acid (ASA), L-nitro arginine methyl ester (L-NAME),
apigenin and atropine were purchased from Sigma (St. Louis, MO.).
Acetic acid, formalin, and morphine hydrochloride were from Merck
Inc., and naloxone was obtained from Cristália (São Paulo, Brazil).
All drugs were dissolved in phosphate buffer saline (PBS) just beforeuriﬁcation from the DCM extract — 98% of purity.
Fig. 3. HPLC of the crude dichloromethane fraction, showing a very complex pattern at around 2–6 min, formed by complex mixtures of triterpenes/other ﬂavonoids. Apigenin is
seeing at 11.45 min.
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in dimethylsulfoxide (DMSO) in order to prepare a stock solution at a
concentration of 100 mg/ml. In all experiments, the ﬁnal concentra-
tion of DMSO did not exceed 0.5% at which had no effect per se. The
ethanol extract and the dichloromethane fraction were administered
by oral gavage, at doses of 10 to 100 mg/kg; apigenin was administered
at 1 mg/kg (p.o.). Morphine (5 mg/kg, s.c.) and ASA (100 mg/kg, p.o.)
were used as reference drugs. The antagonists were used at doses indi-
cated in each protocol. The control groupwas composed by vehicle (PBS
with the same amount of DMSO used in the highest dose).
Peripheral antinociceptive effect
Acetic acid-induced abdominal writhing
The peripheral antinociceptive activity was evaluated in mice
using the writhing test adapted by Pinheiro et al. (2010). Brieﬂy,
mice were pre-treated with vehicle, ASA, morphine, O. speciosa frac-
tions, or apigenin 60 min before intraperitoneal administration of a
2% (v/v) acetic acid solution (AA). The total number of writhing was
recorded over a period of 20 min, starting 5 min after AA injection.
Formalin-induced licking
The procedure was similar to the method described by Hunskaar
and Hole (1987) with some modiﬁcations done by Gomes et al.
(2007). Animals received the injection of 20 μl of formalin (2.5% v/v)
into the dorsal surface of the left hind paw. Immediately, the time that
the animal spent licking the injected pawwas recorded. The nociceptive
and inﬂammatory responses develop two phases: the ﬁrst 5 min
after formalin injection (ﬁrst phase, neurogenic pain response) and
15–30 min after formalin injection (second phase, inﬂammatory
pain response). The animals were pre-treated with oral doses of
vehicle, ASA, morphine, O. speciosa fractions or apigenin, 60 min
before administration of formalin.
Central antinociceptive effects
Hot-plate test
In the central antinociceptive test mice were tested according to the
method described by Sahley and Berntson (1979) and adapted by
Pinheiro et al. (2010). Animals were placed on a hot plate (Insight
equipments, Brazil) set at 55±1 °C. The reaction time for licking
(fore- and hind- paws) and jumping was recorded at several intervals
of 30 min after oral administration of vehicle, morphine, O. speciosa
fractions or apigenin. Baselinewas designated as the average of reaction
time obtained at 60 and 30 min before administration of vehicle, mor-
phine, O. speciosa fractions or apigenin and deﬁned as normal reaction
of animal to the temperature. Increase in baseline (%) was calculated
by the formula: ((reaction time×100)/baseline)−100. The following
formula based on the trapezoid rule (Matthews et al., 1990) wasused to calculate the AUC: AUC=30×IB [(min30)+(min 60)+…+
(min 180)/2], where IB is the increase in baseline (in %).
Evaluation of the mechanism of action of the O. speciosa fractions
and apigenin
To assess whether the opioid, nitric oxide or cholinergic systems are
involved in the antinociceptive action of the dichloromethane fraction
and apigenin from O. speciosa leaves, mice were pre-treated with atro-
pine (1 mg/kg, s.c.), naloxone (1 mg/kg, s.c.), L-nitro arginine methyl
ester (L-NAME, 3 mg/kg, s.c.) or mecamylamine (2 mg/kg, s.c.) 30 min
before receiving ethanol, dichloromethane fraction (30 mg/kg, p.o.),
or apigenin (1 mg/kg, p.o.). The doses of antagonists and NO synthase
inhibitorwere selected based on previous experiments fromour labora-
tory (Pinheiro et al., 2010). Antinociceptionwas quantiﬁed as either the
increase in baseline (%) calculated by the formula (reaction time×100/
baseline)−100, or the AUC of responses from 30 to 180 min after drug
administration.
Acute toxicity
These parameters were determined as previously described by
(Lorke, 1983). A single oral dose of ethanol or dichloromethane frac-
tions (500 mg/kg) was administered to a group of ten mice (ﬁve
males and ﬁve females). Behaviour parameters including convulsion,
hyperactivity, sedation, grooming, loss of righting reﬂex, increased or
decreased respiration, and food and water intake were observed over
a period of 5 days. After this period animals were killed by cervical
dislocation, stomachs were removed, an incision along the greater
curvature was made, and the number of ulcers (single or multiple
erosion, ulcer or perforation) and hyperaemia were counted.
Statistical analysis
All experimental groups were composed by 6–10 mice. The results
are presented as mean±S.D. The area under the curve (AUC) used
was calculated by Prism Software 5.0 (GraphPad Software). Statistical
signiﬁcance between groups was performed by the application of
analyses of variance ANOVA followed by Bonferroni's test. p values
less than 0.05 (pb0.05) were used as the signiﬁcant level.
Results
Isolation and characterization of Apigenin
The phytochemical study was performed with the dichloromethane
fraction from O. speciosa leaves. After several chromatographic proce-
dures, a compound was isolated from the very complex and mixed
crude dichloromethane fraction and identiﬁed by NMR analysis as the
ﬂavonoid 5,7,4-trihydroxyﬂavone, known as apigenin (Fig. 1). This
was conﬁrmed by means of TLC and HPLC analysis (Figs. 2 and 3).
Fig. 4. Effects of oral administration of the ethanolic extract and dichloromethane fraction of Orbignya speciosa Mart. leaves on the acetic acid-induced abdominal writhing (A) and
formalin test (B) in mice. Controls groups were composed by vehicle, morphine (5 mg/kg, s.c.) and acetylsalicylic acid (ASA, 100 mg/kg, p.o.). Results were presented are mean±
S.D. (n=6–10) of total of number of writhes or lickings. *pb0.005 ANOVA followed by Bonferroni's test when comparing morphine, acetilsalicilic acid, ethanolic extract and
dichloromethane fraction -treated mice with vehicle-treated group.
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dichloromethane fractions
Injection of acetic acid into the peritoneal cavity of mice develops
51.5±6.9 writhing in an interval of 20 min. The pre-treatment of
animals with different doses of ethanol and dichloromethane frac-
tions (10 to 100 mg/kg) resulted in a signiﬁcant inhibition on
writhing, indicating a peripheral antinociceptive effect (Fig. 4). The
highest antinociceptive effect from both fractions was observed
with the dose of 10 mg/kg (48.7 and 66.8% reduction; 51.5±6.9 in
control group versus 26.4±2.2 and 16.6±5.8 for ethanol and
dichloromethane fractions, respectively). Despite this result, there
was no signiﬁcant difference between the three doses tested
(Fig. 4A).
Fig. 4B shows the inhibitory effect of ethanol and dichloromethane
fractions in the model of formalin-induced licking response.
Intraplantar injection of formalin resulted in a two-phase nociceptive
behaviour in mice. In the ﬁrst phase (neurogenic phase), the response
was immediate and lasted up to 5 min following formalin injection
resulting in the licking time of the 47.8±12.1 s whereas the second
phase (inﬂammatory phase) began at 15 min and lasted up to
30 min and resulted in 136.1±13.3 s. The oral administration of eth-
anol fraction before formalin stimulus decreased the licking behaviour
in both phases. Dichloromethane fractionwas also able to signiﬁcantly
reduce both phases. The dose of 100 mg/kg inhibited 78% (47.8±
12.1 s in control group versus 10.5±4.1 in dichloromethane-treated
group) and 62% (136.1±13.2 s in control group versus 51.6±8.1 s
in dichloromethane-treated group) the licking response in the ﬁrst
and second phase, respectively (Fig. 4B). It is interesting to note that
both fractions had an inhibitory effect similar to that obtained with
acetylsalicylic acid (100 mg/kg).Central antinociceptive effect from ethanol and dichloromethane fractions
The pre-treatment of animals with the ethanol extract and dichlo-
romethane fraction also resulted in a central antinociceptive effect.
Both fractions increased the time of response from animals in the hot
plate model. All three doses signiﬁcantly increased the baseline (when
comparing with vehicle-treated group). It is also interesting to note
that the doses of 30 and 100 mg/kg from both fractions demonstrated
an anti-hyperalgesic effect higher than morphine-treated animals
(Fig. 5).
Apigenin isolated from dichloromethane fraction develops a peripheral
and central antinociceptive effect
The apigenin isolated from the dichloromethane fraction was
evaluated for its antinociceptive potential. Thus, a dose 1 mg/kg was
used based on the amount in the dichloromethane fraction. The
pre-treatment of mice with apigenin resulted in a signiﬁcant reduc-
tion in the writhing induced by i.p. injection of acetic acid. This effect
was similar to that observed with ASA or morphine-treated animals
(Fig. 6A). Apigenin also reduced the licking response in the ﬁrst and
second phase of formalin model. In the 1st phase the effect was sim-
ilar to morphine and in the 2nd phase the effect was similar to that of
ASA.
Evaluation of the mechanism of action of dichloromethane fraction and
apigenin
The anti-hyperalgesic effect observed in the hot plate model is
indicative that fractions and apigenin has central antinociceptive
activity. The next step was then to evaluate the antinociceptive
Fig. 5. Effects of oral administration of the ethanol extract and dichloromethane fraction of Orbignya speciosaMart. leaves on the hot plate model. Controls groups were composed by
vehicle or morphine (5 mg/kg, s.c.). Results were presented are mean±S.D. (n=6–10) of increase in baseline or area under the curve. *pb0.005 ANOVA followed by Bonferroni's
test when comparing morphine, ethanol extract, and dichloromethane fraction-treated mice with vehicle-treated group and #pb0.005, ANOVA followed by Bonferroni's test when
comparing ethanol extract and dichloromethane fraction-treated mice with morphine-treated group.
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groups and treated with different antagonists 30 min before oral ad-
ministration of dichloromethane fraction (30 mg/kg) or apigenin
(1 mg/kg). The results demonstrate that the anti-hyperalgesic effect
of dichloromethane fraction observed in the hot plate model was re-
versed by the pre-treatment of mice with atropine (1 mg/kg, s.c.),
naloxone (1 mg/kg, s.c.), mecamylamine (2 mg/kg, s.c.) or L-NAME
(3 mg/kg). The same antagonists were used to evaluate the mecha-
nism of action from apigenin. Our results demonstrate that only atro-
pine and naloxone signiﬁcantly reduced the antinociceptive effect
from apigenin (Fig. 7).
Acute toxicity
To evaluate possible toxic effects on mice, 500 mg/kg of ethanol
extract, dichloromethane fraction, or apigenin were orally adminis-
tered. After 5 days of a single administration, treated mice did not pre-
sent behavioural changes and no lesions or bleedings in stomachs were
observed. Any signals of intoxication such as convulsion, death, gastric
ulcer was present during the days of observation. These results indicate
that the treatment with ethanol extract, dichloromethane fraction or
apigenin was nontoxic in animals up to the oral dose of 500 mg/kg.
Discussion
In this study, we have demonstrated that ethanol extract and dichlo-
romethane fraction from O. speciosa leaves produce antinociceptive ef-
fect when tested on peripheral and central models.
The intraperitoneal injection of acetic acid induced a pain-related
behaviour of writhing. This algesic response involves the intraperito-
neal liberation of several mediators, such as neurotransmitters and
neuromodulators, kinins, histamine, acetylcholine, substance P, and
prostaglandins (Deraedt et al., 1980; Cervero and Laird, 1999). Thesemediators increase vascular permeability, reduce the threshold of the
nociception and stimulate the nervous terminal of nociceptive ﬁbers.
The effect obtained with ethanol extract and dichloromethane fraction
may be related with the reduction on the liberation of those inﬂamma-
tory mediators into the peritoneal cavity or by direct blockage of its
receptors resulting in an antinociceptive effect. Also their activity
could be due to an enhancement on the nociceptive threshold or by
the interruption of the stimulus propagation in the pain nervous ﬁbre.
The injection of formalin induced a pain-related licking response
of the injected paw in two distinct phases. The ﬁrst phase is charac-
terized by neurogenic pain caused by direct chemical stimulation of
nociceptors. The second phase is characterized by inﬂammatory
pain triggered by a combination of stimuli — inﬂammation of the pe-
ripheral tissues and mechanisms of central sensitization. In this latter
phase, different mediators are involved, as excitatory amino acids,
neuropeptides, nitric oxide, PGE2, and kinins (Tjolen et al., 1992). Var-
ious studies have reported that both phases are sensitive to central
action drugs, as opioids. However, the second phase is also sensitive
to nonsteroidal anti-inﬂammatory analgesic and corticosteroids
(Hunskaar and Hole, 1987). Our results showed that ethanol and di-
chloromethane fractions decreased both phases of the licking response
induced by formalin. These results indicate that these fractions could be
acting via inhibition of any inﬂammatory mediator liberated in mice
paw. They could inhibit the formation and/or liberation of those medi-
ators or directly blocking it receptor. These results corroborate with
the inhibitory effect of O. speciosa leaves on the acetic acid-induced
writhing response. Although we observed an inhibitory effect in both
models, we did not get a dose response curve. This is probably due to
synergism/antagonism between several substances presented in the
ethanol extract or in the dichloromethane fraction.
Due to the observation that the fractions were able to inhibit the
ﬁrst phase of the formalin response (neurogenic phase), we decided
to test the fractions in a model of central antinociceptive activity,
Fig. 6. Effects of oral administration different doses of apigenin on the acetic acid-induced abdominal writhing (A), formalin test (B), and hot plate (C) in mice. Controls groups were
composed by vehicle, morphine (5 mg/kg, s.c.) and acetylsalicylic acid (100 mg/kg, p.o.). Results were presented are mean±S.D. (n=6–10) of total of number of writhes, lickings,
or increase in baseline. *pb0.005 ANOVA followed by Bonferroni's test when comparing apigenin-treated mice with vehicle-treated group.
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fraction developed an antinociceptive effect greater than morphine
(at doses of 30 and 100 mg/kg).
To test the hypothesis that the antinociceptive effect of dichlo-
romethane fraction could be due to the presence of apigenin, the ﬂa-
vonoid isolated in the fraction, we use the same models mentioned
above. We observed that the apigenin treatment with the doses of 1
or 3 mg/kg induced an inhibitory effect in acetic acid-induced contor-
tions and formalin-induced licking (1st and 2nd phases), indicating a
peripheral antinociceptive activity. It was interesting to note that
apigenin effect was similar to or greater than the drugs used as posi-
tive control groups, morphine and ASA. Apigenin also demonstrated a
central antinociceptive effect, increasing the area under the curve in
the hot plate model. Some studies have reported the anti-cancer,
anti-oxidant, anti-inﬂammatory, and neuroprotective proﬁles to the
ﬂavonoid apigenin (Kowalski et al., 2005; Lee et al., 2007; Nicholas
et al., 2007; Ha Keun et al., 2008; Zhong et al., 2010), but to the best
of our knowledge this is the ﬁrst study that demonstrated the anti-
nociceptive activity of apigenin.
In order to determine the mechanism involved in the central
antinociception caused by dichloromethane fraction and apigenin
classical antagonists of cholinergic and opioid receptors (atropine,
mecamylamine, and naloxone, respectively) and an inhibitor of nitricoxide pathway (L-NAME), was used. The results indicate that there is
an involvement of cholinergic receptors since atropine inhibited the
antinociceptive effect of dichloromethane fraction and apigenin. A
major site of action for cholinomimetics in analgesia is the spinal
cord. Painful stimuli are known to increase acetylcholine in the spinal
cord. The activation of muscarinic receptors in the spinal cord results
in an increased release of inhibitory transmitters alongwith a decrease in
the release on excitatory transmitters, and this in partmediates their anti-
nociceptive effects (Jones and Dunlop, 2007). Based on these evidences, it
is possible that some substances in dichloromethane fraction as well as
apigenin activate cholinergic receptors resulting in an antinociceptive
effect. The dichloromethane fraction contains apigenin and other com-
pounds. This explains why the treatment with all four antagonists has re-
versed the antinociceptive effect from dichloromethane fraction and only
two of them have inhibited the antinociceptive effect from apigenin.
Our results also demonstrated that dichloromethane fraction and
apigenin activities seem to involve the participation of opioid system.
Both dichloromethane fraction and apigenin effects were reversed by
naloxone, similarly to the compounds morphine-like. Together, these
data are consistent with the interpretation that systemically adminis-
tered morphine exerts its analgesic effects by interacting with both
central and peripheral opioid receptors (Perrot et al., 2001; Shannon
and Lutz, 2002).
Fig. 7. Effects of different antagonists on antinociceptive activity of dichloromethane fraction of Orbignya speciosa Mart. leaves and apigenin in the hot plate model. Animals were
pre-treated with atropine (1 mg/kg, s.c.), L-NAME (3 mg/kg, s.c.), naloxone (1 mg/kg, s.c.) or mecamylamine (2 mg/kg, s.c.) 30 min prior to oral administration of dichloromethane
fraction (30 mg/kg) or apigenin (1 mg/kg). The results are presented as mean±S.D. (n=6–10) of increase in baseline (%) calculated as described in methods (left graphs) and of
area under the curve (right graphs) calculated by Prisma Software 5.0. Statistical signiﬁcance was calculated by ANOVA followed by Bonferroni's test. *pb0.005 when comparing mor-
phine, dichloromethane or apigenin-treatedmice with vehicle-treated group and #pb0.005 when comparing antagonists treatedmice with dichloromethane or apigenin-treated group.
299M.M.G. Pinheiro et al. / Life Sciences 91 (2012) 293–300Conclusion
The present study demonstrated that the fractionation of the
O. speciosa Mart. leaves resulted in the isolation and identiﬁcation of
the ﬂavonoid apigenin in the dichloromethane fraction from leaves.
The evidences supports our hypothesis suggesting that apigenin
may contribute to the antinociceptive effect observed and that the
opioid and cholinergic systems are involved in this effect.Conﬂict of interest statement
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